\
&
Contact us
\
&
Contact us
Starts in 3 weeks from now
LocationBrussels
The Commission’s Advanced Digital Skills and Women in Digital flagships will join forces for a combined stakeholder event, providing a key moment to accelerate progress towards the Digital Decade target of 20 million ICT specialists and greater gender balance in tech.
This cooperation reflects the EU’s ambition set out in the Union of Skills and AI Continent Action Plan: to boost Europe’s global leadership and competitiveness through highly skilled talent and strengthen its capacity to lead in advanced digital technologies.
The Summits invite the most relevant stakeholders and leaders from industry, education, training and policy to share the latest state-of-play, data, best practice and promote joint actions to unlock the talent pipeline and lay the foundations of the future advanced digital skills academies.
Registrations are expected to open soon. For more information on the event and the applications for the European Digital Skills Awards (deadline 15 July), please visit the event website.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Health AI Continent Deployment: Best use of technologies
Security Digital, Industry & Space Cybersecurity
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
